Menopause is often discussed in relation to hot flushes, sleep disturbance, bone loss and changes in body composition. However, it is also an important stage for cardiovascular prevention. Cardiovascular disease (CVD) becomes increasingly common after menopause, and evidence suggests that the menopausal transition itself is accompanied by changes in several cardiometabolic and vascular risk factors—not simply by chronological ageing alone (El Khoudary et al., 2020).

Exercise therefore has a particularly important role in midlife. It cannot remove every cardiovascular risk factor, but it can improve cardiorespiratory fitness, blood pressure, vascular function, glucose regulation, body composition and lipid profiles while simultaneously supporting musculoskeletal and psychological health.

Why Does Cardiovascular Risk Change Around Menopause?

The relationship between menopause and cardiovascular health is more complex than a simple “loss of estrogen causes heart disease” explanation.

During the menopausal transition, ovarian hormone patterns change while women are simultaneously experiencing chronological ageing and possible changes in physical activity, sleep, body composition and metabolic health. Longitudinal evidence has identified adverse changes in LDL cholesterol, visceral adiposity, metabolic risk and vascular health during this period. Earlier natural menopause is also associated with greater later cardiovascular risk (El Khoudary et al., 2020).

Several changes may therefore occur together:

These changes do not occur equally in every woman. Smoking, family history, hypertension, diabetes, dyslipidaemia, obesity, premature menopause and previous cardiovascular disease may substantially modify individual risk.

For clinicians, the practical message is important: midlife should be considered a cardiovascular prevention window rather than a point at which risk is accepted as inevitable.

How Does Exercise Protect the Cardiovascular System?

Regular exercise produces adaptations across several systems rather than acting on a single risk factor.

Aerobic exercise increases the capacity of the heart, circulation and skeletal muscles to deliver and utilise oxygen. With training, submaximal activities can be performed at a lower relative physiological cost, while cardiorespiratory fitness improves. Higher fitness is strongly associated with better long-term cardiovascular outcomes.

Exercise can also improve endothelial function and vascular regulation, reduce resting blood pressure and enhance autonomic balance. Repeated muscular activity increases glucose uptake and improves insulin sensitivity, while sustained training can reduce visceral adiposity and improve aspects of the lipid profile.

Resistance training adds another important component. Maintaining or increasing skeletal-muscle mass supports glucose disposal, functional capacity and metabolic health. It also allows women to remain physically active at higher levels as they age. The American Heart Association now recognises resistance training as an important component of cardiovascular health rather than viewing strength exercise only as a musculoskeletal intervention (Paluch et al., 2024).

This gives physiotherapists an important clinical principle:

Cardiovascular exercise after menopause should not automatically mean walking alone. Aerobic and progressive resistance training are complementary.

What Does Current Evidence Show?

Recent evidence provides increasingly strong support for exercise in postmenopausal women.

A 2024 systematic review and meta-analysis involving more than 4,000 postmenopausal women found that aerobic training improved systolic blood pressure, resting heart rate, waist circumference, body fat, LDL cholesterol, HDL cholesterol and cardiorespiratory fitness. Systolic blood pressure decreased by approximately 4.4 mmHg, waist circumference by about 2 cm, and LDL cholesterol by approximately 10 mg/dL across included studies (Huynh et al., 2024). The authors did, however, rate certainty for several outcomes as very low because exercise protocols and study populations varied considerably.

A separate 2025 meta-analysis of 61 randomised trials reported similar findings. Aerobic exercise reduced systolic blood pressure by approximately 4.5 mmHg and diastolic pressure by 2.4 mmHg, while also producing modest improvements in HDL, LDL and triglycerides (Weber et al., 2025).

Resistance training is also gaining menopause-specific cardiovascular evidence. A 2026 systematic review found significant improvements in resting heart rate and blood pressure after resistance training in postmenopausal women, together with modest improvements in vascular and autonomic outcomes (Rivera-Mejía et al., 2026).

Importantly, newer research suggests that multicomponent exercise may be especially useful. A 2026 dose-response network meta-analysis involving 79 trials and 3,628 postmenopausal women found clinically meaningful reductions in blood pressure across exercise modalities, with combined or multicomponent exercise producing particularly consistent results. Around 900 MET-minutes/week of multicomponent exercise ranked highly for blood pressure reduction, although the overall certainty of evidence remained low to very low (Zhang et al., 2026). This should therefore guide programme design rather than be treated as a rigid prescription for every patient.

Practical Exercise Prescription After Menopause

For most healthy midlife and postmenopausal women, the overall cardiovascular exercise targets are similar to those recommended for adults generally, but prescription should be individualised according to baseline fitness, symptoms, cardiovascular risk and musculoskeletal capacity.

These recommendations are consistent with World Health Organization physical-activity guidance and current exercise-prescription principles (American College of Sports Medicine [ACSM], 2025; World Health Organization [WHO], 2020).

For moderate aerobic exercise, the talk test is often clinically useful: the patient should be able to speak in sentences but should clearly feel that she is exercising. Heart-rate targets can also be used when appropriate, although medication, autonomic responses and individual fitness may alter heart-rate behaviour.

A practical programme might include brisk walking or cycling on three to five days per week combined with two or three progressive resistance-training sessions. The programme should become progressively more challenging as tolerance improves rather than remaining permanently at the same workload.

The Physiotherapist's Role: Assess, Prescribe and Progress

Physiotherapists are well placed to translate general physical-activity advice into an individualised cardiovascular programme.

Assessment should begin with the patient's menopause and medical history, current physical activity, cardiovascular risk factors, medications and previous exercise experience. Resting blood pressure and heart rate are useful baseline measures, together with relevant anthropometric and functional findings.

Depending on the clinical setting, aerobic capacity may be assessed using a 6-minute walk test, step test, cycle or treadmill assessment, while functional strength can be screened using measures such as sit-to-stand performance. Exercise should then be prescribed according to the patient's functional capacity rather than age alone.

Progression may follow a simple clinical sequence:

Low baseline activity → regular tolerable movement → continuous moderate aerobic exercise → progressive resistance training → increased duration or intensity → long-term independent exercise

Symptoms should also guide decision-making. New exertional chest pressure, unexplained syncope, marked palpitations, disproportionate breathlessness or other concerning cardiovascular symptoms require appropriate medical evaluation rather than simply increasing exercise intensity.

Women with known cardiovascular disease may require structured cardiovascular rehabilitation and more specific exercise testing or monitoring. Current AHA guidance also emphasises the importance of improving participation and individualising cardiac rehabilitation for women with established disease (Coutinho et al., 2025).

Exercise Is Foundational—but It Is Not the Whole Treatment Plan

Exercise should be considered part of comprehensive cardiovascular prevention.

Blood pressure, lipid profile, blood glucose or HbA1c, smoking, nutritional intake, sleep and family history should also be considered. Patients with hypertension, diabetes or dyslipidaemia may still require medication even when exercising regularly.

Similarly, menopausal hormone therapy and exercise answer different clinical questions. Hormone therapy may be appropriate for selected women with troublesome menopausal symptoms after individualised risk assessment, but it should not be self-prescribed as a cardiovascular prevention strategy or viewed as a substitute for physical activity. Cardiovascular risk and menopausal symptom management should instead be considered together within multidisciplinary care.

For physiotherapists, this reinforces an important point: we are not treating “menopause” with exercise. We are using exercise to address modifiable cardiovascular, metabolic and functional consequences that become increasingly relevant during midlife and after menopause.

Viva-Ready Summary

Cardiovascular risk rises during and after the menopausal transition because of the combined influence of reproductive ageing, chronological ageing and traditional cardiovascular risk factors.
Important changes may include increased LDL cholesterol, visceral adiposity, insulin resistance, blood pressure and vascular dysfunction.
Aerobic exercise improves cardiorespiratory fitness and can reduce blood pressure, abdominal adiposity and adverse lipid parameters.
Resistance training contributes to cardiovascular health while preserving muscle mass, strength and metabolic capacity.
Current evidence increasingly supports combined aerobic and resistance exercise rather than relying on one exercise modality alone.
Most women should work toward 150–300 minutes of moderate aerobic activity each week plus muscle-strengthening exercise on at least two days.
Exercise prescription should be individualised according to cardiovascular risk, symptoms, baseline fitness and comorbidities.
Exercise complements—not replaces—appropriate management of hypertension, diabetes, dyslipidaemia or established cardiovascular disease.

One-line recall:
Menopause creates an important cardiovascular prevention window, and regular aerobic plus resistance exercise helps protect the heart by improving fitness, blood pressure, metabolic health, vascular function and body composition.

References

American College of Sports Medicine. (2025). ACSM's guidelines for exercise testing and prescription (12th ed.). Wolters Kluwer.

Coutinho, T., Khadanga, S., Adedinsewo, D., Barac, A., Brown, T. M., Deaton, C., Golbus, J. R., Reynolds, H., Sharma, G., & Taylor, J. L. (2025). Cardiac rehabilitation in women: A scientific statement from the American Heart Association. Circulation, 152, e376–e390. https://doi.org/10.1161/CIR.0000000000001379

El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D., Limacher, M. C., Manson, J. E., Stefanick, M. L., & Allison, M. A. (2020). Menopause transition and cardiovascular disease risk: Implications for timing of early prevention: A scientific statement from the American Heart Association. Circulation, 142(25), e506–e532. https://doi.org/10.1161/CIR.0000000000000912

Hall, J. E., & Hall, M. E. (2025). Guyton and Hall textbook of medical physiology (15th ed.). Elsevier.

Huynh, E., Wiley, E., Noguchi, K. S., Fang, H., Beauchamp, M. K., MacDonald, M. J., & Tang, A. (2024). The effects of aerobic exercise on cardiometabolic health in postmenopausal females: A systematic review and meta-analysis of randomized controlled trials. Women's Health, 20, 17455057241290889. https://doi.org/10.1177/17455057241290889

Paluch, A. E., Boyer, W. R., Franklin, B. A., Laddu, D., Lobelo, F., Lee, D.-C., McDermott, M. M., Swift, D. L., Webel, A. R., & Lane, A. (2024). Resistance exercise training in individuals with and without cardiovascular disease: 2023 update: A scientific statement from the American Heart Association. Circulation, 149, e217–e231. https://doi.org/10.1161/CIR.0000000000001189

Rivera-Mejía, S. L., Rúa-Alonso, M., Rial-Vázquez, J., Nine, I., Camacho-Villa, M. A., Enríquez-González, M. G., Varela-Sanz, A., Fariñas, J., Revuelta-Lera, B., Fraga-Germade, E., Giráldez-García, M. A., & Iglesias-Soler, E. (2026). Resistance training improves cardiovascular health in postmenopausal women: Systematic review and meta-analysis. Journal of Applied Physiology. Advance online publication. https://doi.org/10.1152/japplphysiol.01180.2025

Weber, A. C., Migliavaca, C. B., Tavares, A. L., Carvalho, G. D. S., Pasin, J. K., Valter, L. K., Kaminski, M. E., Alt, V. R., Spielmann, F. V. J., & Wender, M. C. O. (2025). Impact of aerobic exercise on cardiovascular and mental health in postmenopausal women: A systematic review and meta-analysis. Menopause, 32(8), 779–789. https://doi.org/10.1097/GME.0000000000002552

World Health Organization. (2020). WHO guidelines on physical activity and sedentary behaviour. World Health Organization.

Zhang, J., Yu, A. P.-H., Poon, E. T.-C., & Wong, S. H.-S. (2026). Comparative dose-response effects of exercise modalities on blood pressure in post-menopausal women: A systematic review with dose-response network meta-analyses. European Journal of Preventive Cardiology. Advance online publication. https://doi.org/10.1093/eurjpc/zwag103